Brief: Cano Health Announces Q4 Results
March 1 (Reuters) - Cano Health Inc CANO.N :
* QTRLY TOTAL REVENUE OF $680.4 MILLION, COMPARED TO $492.3
MILLION PRIOR YEAR, AN INCREASE OF 38% YEAR-OVER-YEAR
* SEES 2023 TOTAL REVENUE IN RANGE OF $3.10 BILLION TO $3.25
BILLION
* QTRLY NET LOSS PER SHARE ATTRIBUTABLE TO CLASS A COMMON
STOCKHOLDERS, DILUTED $0.61
* Q4 EARNINGS PER SHARE VIEW $-0.13, REVENUE VIEW $654.5
MILLION
-- REFINITIV IBES DATA
Source text for Eikon: ID:nPnyVR4Xa
Further company coverage: CANO.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cano Health
See all newsBrief: Carlyle Group Inc. Reports 6.7% Stake In Cano Health, Inc. As Of June 28, 2024 - SEC Filing
Brief: Cano Health Says Emergence From Chapter 11 Expected In Q3 Of 2024
Brief: Cano Health Inc Says DIP Lenders Will Provide New Financing Commitments To Cano Health, LLC Under New Money Delayed Draw Term Loan Facility Of $150 mln
Brief: NYSE Suspends Trading In Cano Health And Commences Delisting Proceedings
U.S. STOCKS ON THE MOVE-MorphoSys AG, DocuSign, Invitae